Ludwig Kurt Merckle (born 1965) is a German businessman.
Ludwig Kurt Merckle earned a degree in business information technology (Diplom-Wirtschaftsinformatiker) from the University of Mannheim.
[2] Merckle started his career as a strategic consultant at Roland Berger in 1993.
In 2005, he was appointed CEO of VEM Vermögensverwaltung GmbH, and in 2009, CEO of Merckle Service GmbH,[2] after his father committed suicide and left the family group in debt.
[3] In March 2010, the generic drugmaking arm of Merckle, Ratiopharm, was sold to Teva Pharmaceutical Industries for €3.6 billion, 55% of HeidelbergCement for €2.5 billion, and other assets to clear their debts.